Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Most Recent

  • September 04 2019

    PolyPid Ltd., a clinical-stage biopharmaceutical company in Israel, conducted the final closing of its Series E-1 preferred share private placement offering which raised gross proceeds of $50,000,000.  EG&S acted as counsel to National Securities Corporation, the U.S. placement agent for the offering.

  • August 14 2019

    DelMar Pharmaceuticals, Inc. announced the closing of its underwritten public offering in the amount of $6,800,000.  EG&S acted as counsel to Maxim Group LLC, the book-running manager in the offering.

  • August 13 2019

    Thunder Bridge Acquisition, II Ltd. announced the closing of its initial public offering in the amount of $345,000,000.  EG&S acted as counsel to Thunder Bridge.

Posts

  • August 09 2019

    Titan Pharmaceuticals, Inc. announced the closing of its registered direct offering in the amount of $2,100,000. EG&S acted as counsel to Maxim Group, the sole placement agent in the offering.

  • August 08 2019

    Mitchell F. Borger, a member of the Firm, wrote an article for Total Food Service titled: A Restaurateur’s Day Goes Bad – Reacting To A Workplace Harassment Complaint.

  • August 05 2019

    Douglas S. Ellenoff, a member of the Firm, spoke at the Alternative Finance Summit 2019: Marketplace Lending, Cryptocurrency and Crowdfunding. Mr. Ellenoff participated in a panel discussion entitled “Special Purpose Acquisition Companies and Closed-End Funds.”

  • August 01 2019

    SG Blocks, Inc. announced the closing of its shelf underwritten public offering in the amount of $765,000. EG&S acted as counsel to ThinkEquity, representative of the underwriters in the offering.

  • July 31 2019

    Ilan Weiser, an associate of the Firm, authored a great article for Total Food Service titled: “Less is More”: How To Avoid Being Deemed A Joint Employer With A Staffing Agency.

    Click here to read the article.

  • June 25 2019

    Artelo Biosciences, Inc. announced the closing of its underwritten public offering in the amount of $8,000,000. EG&S acted as counsel to Maxim Group LLC, the the sole book-running manager for the offering.

  • February 08 2019

    Douglas S. Ellenoff, a member of the Firm, was invited by Deal Flow Events to open the SPAC Conference 2019 with the keynote address.  EGS served as the premier sponsor.

  • August 17 2017

    Richard P. Kaye, a member of the Firm, along with senior litigation associate John Horgan, and litigation associates Joanna Cohen and Anne O’Malley, successfully vacated a judgement of approximately $500,000 against a client. After oral argument and two evidentiary hearings, EGS attorneys established that the client had never signed a retainer agreement with the attorney who purported to represent him in Court; having never been served personally and never appeared through counsel, the Court had no jurisdiction over him to enter the $500,000 judgment.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”